An injectable composite material containing bone morphogenetic protein-2 shortens the period of distraction osteogenesis in vivo

Journal of Orthopaedic Research

Volumn 29, Issue 3, 2011, Pages 452-456

  Eguchi, Yoshitaka ^a   Wakitani, Shigeyuki ^a   Naka, Yoshifumi ^a   Nakamura, Hiroaki ^a   Takaoka, Kunio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

tricalcium phosphate; bone morphogenetic protein 2; bone transport

Indexed keywords

CALCIUM PHOSPHATE; CEFAZOLIN; MACROGOL; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DEFECT; BONE RADIOGRAPHY; CALLUS; COMPOSITE MATERIAL; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; HISTOLOGY; IN VIVO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONY CALLUS; CALCIUM PHOSPHATES; DIAPHYSES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; MALE; OSTEOGENESIS, DISTRACTION; RABBITS; RECOMBINANT PROTEINS; TIBIAL FRACTURES;

EID: 79251579978     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21225     Document Type: Article

References (22)

1. Ilizarov GA,. 1989. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res 239: 263-285.
2. Paley D, Maar DC,. 2000. Ilizarov bone transport treatment for tibial defects. J Orthop Trauma 14: 76-85.
3. DeCoster TA, Gehlert R, Mikola EA, et al. 2004. Management of posttraumatic segmental bone defects. J Am Acad Orthop Surg 12: 28-38.
4. Wang Y, Ni M, Tang PF, et al. 2009. Novel application of HA-TCP biomaterials in distraction osteogenesis shortened the lengthening time and promoted bone consolidation. J Orthop Res 27: 477-482.
5. Yano K, Hoshino M, Ohta Y, et al. 2009. Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing. J Bone Miner Metab 27: 355-363.
6. DeCoster TA, Simpson AH, Wood M, et al. 1999. Biologic model of bone transport distraction osteogenesis and vascular response. J Orthop Res 17: 238-245.
7. White SH, Kenwright J,. 1990. The timing of distraction of an osteotomy. J Bone Joint Surg Br 72: 356-361.
8. Li G, Bouxsein ML, Luppen C, et al. 2002. Bone consolidation is enhanced by rhBMP-2 in a rabbit model of distraction osteogenesis. J Orthop Res 20: 779-788.
9. Yasko AW, Lane JM, Fellinger EJ, et al. 1992. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 74: 659-670.
10. Cohen J,. 1968. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70: 213-220.
11. Namikawa T, Terai H, Hoshino M, et al. 2007. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine 32: 2294-2299.
12. Wang Y, Wan C, Szoke G, et al. 2008. Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis. J Orthop Res 26: 539-546.
13. Wang L, Zhou S, Liu B, et al. 2006. Locally applied nerve growth factor enhances bone consolidation in a rabbit model of mandibular distraction osteogenesis. J Orthop Res 24: 2238-2245.
14. Sato M, Ochi T, Nakase T, et al. 1999. Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res 14: 1084-1095.
15. Hu J, Qi MC, Zou SJ, et al. 2007. Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. J Orthop Res 25: 241-251.
16. Sailhan F, Gleyzolle B, Parot R, et al. 2009. Rh-BMP-2 in distraction osteogenesis: Dose effect and premature consolidation. Injury 41: 754-760.
17. Khanal A, Yoshioka I, Tominaga K, et al. 2008. The BMP signaling and its Smads in mandibular distraction osteogenesis. Oral Dis 14: 347-355.
18. Theyse LF, Oosterlaken-Dijksterhuis MA, van Doorn J, et al. 2006. Expression of osteotropic growth factors and growth hormone receptor in a canine distraction osteogenesis model. J Bone Miner Metab 24: 266-273.
19. Li G, Simpson A, Kenwright J, et al. 1999. Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 17: 362-367.
20. Ikeda K, Tomita K, Tanaka S,. 2000. Experimental study of peripheral nerve injury during gradual limb elongation. Hand Surg 5: 41-47.
21. Valentin-Opran A, Wozney J, Csimma C, et al. 2002. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 110-120.
22. Govender S, Csimma C, Genant HK, et al. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A: 2123-2134.